![All lanes : Anti-LGALS3BP antibody [3G8] (ab123921) at 1/500 dilutionLane 1 : HEK293T cell lysate, transfected with pCMV6-ENTRY control cDNA Lane 2 : HEK293T cell lysate, transfected with pCMV6-ENTRY LGALS3BP cDNA Lysates/proteins at 5 µg per lane.](http://www.bioprodhub.com/system/product_images/ab_products/2/sub_3/15850_LGALS3BP-Primary-antibodies-ab123921-1.jpg)
All lanes : Anti-LGALS3BP antibody [3G8] (ab123921) at 1/500 dilutionLane 1 : HEK293T cell lysate, transfected with pCMV6-ENTRY control cDNA Lane 2 : HEK293T cell lysate, transfected with pCMV6-ENTRY LGALS3BP cDNA Lysates/proteins at 5 µg per lane.

ab123921 at 1/100 dilution staining LGALS3BP in HEK293T cells transfected with either pCMV6-ENTRY LGALS3BP (Red) or empty vector control plasmid (Blue) by flow cytometry.

ab123921 at 1/100 dilution staining LGALS3BP in COS7 cells transiently transfected with pCMV6-ENTRY LGALS3BP by Immunofluorescence.

ab123921 at 1/150 dilution staining LGALS3BP in Paraffin-embedded Human Endometrium adenocarcinoma tissue by Immunohistochemistry.

ab123921 at 1/150 dilution staining LGALS3BP in Paraffin-embedded Human Prostate tissue by Immunohistochemistry.

ab123921 at 1/150 dilution staining LGALS3BP in Paraffin-embedded Human Bladder carcinoma tissue by Immunohistochemistry.